5-Azacytidine partially restores CD20 expression in follicular lymphoma that lost CD20 expression after rituximab treatment: a case report

BACKGROUND: The loss of CD20 protein expression after a rituximab-containing regimen is one of the resistance mechanisms in non-Hodgkin's lymphoma. Recently, it was reported that 5-azacitidine administration upregulates the expression of CD20 in CD20-negative B-cell acute lymphoblastic leukemia...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Med Case Rep
Auteurs principaux: Tsutsumi, Yutaka, Ohigashi, Hiroyuki, Ito, Shinichi, Shiratori, Souichi, Teshima, Takanori
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2016
Sujets:
Case Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4739428/
https://ncbi.nlm.nih.gov/pubmed/26838941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-016-0809-7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires